Bio-Implants Market worth $134.3 Billion by 2017


Posted July 15, 2016 by ryan_smith

Bio-Implants Market (Cardiovascular, Orthopaedics, Neurostimulation, Xenografts, Allografts and Others) Competitive Analysis and Global Forecast to 2017

 
According to a new market research report the Bio-Implants Market is expected to be worth $134.3 Billion by 2017.

Browse 83 tables spread through 195 pages and in-depth TOC on "Bio-Implants Market”

http://www.marketsandmarkets.com/Market-Reports/bio-implants-market-728.html

Early buyers will receive 10% customization on reports.

Bio-implants are defined as bioengineered products, employed in tissues or in human living cells with the assistance of active agents or synthetic constructs used to reproduce certain physiological functions or to treat the cause of the disease. The bio-implants market has brought about a paradigm shift in the medical device industry with more demand for biological implants in cardiology, vascular therapy, orthopaedics, trauma, spine, dental, and wound care divisions. Certain bioactive implants such as drug eluting stents, hormonal implants, and implantable drug pumps also form part of this market.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=728

The global bio-implants market was valued at $94.1 billion in the year 2012; North America was the largest market, followed by Europe, and Asia. The U.S. market is expected to face a slump in the coming years due to austerity measures taken by the Federal Government and rise in taxation caused due to the economic crisis of 2008. Uncertainty also prevails in the European region with the Euro crisis; hence, growth is expected to be minimal in this region for the next five years. Asia, however, will showcase higher growth mainly due to large investments from foreign firms and government funding.

Get Report Sample @ http://www.marketsandmarkets.com/requestsample.asp?id=728

The major players in bio-implants market are Stryker Corporation (U.S.), Synthes (U.S.), Boston Scientific Corporation (U.S.), Biomet, Inc. (U.S.), Smith and Nephew (U.K.), Medtronic (U.S.), St. Jude Medical, Inc. (U.S.), and Tornier N.V. (The Netherlands).

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Markets and Markets
Website Bio-Implants Market worth $134.3 Billion by 2017
Phone 1-888-600-6441
Business Address UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Country India
Categories Biotech , Health , Medical
Tags allografts , bio , implants , market , neurostimulation , orthopaedics , xenografts
Last Updated July 15, 2016